Section Editors

Cris S Constantinescu - Professor, Division of Clinical Neurology, University of Nottingham, Queen's Medical Centre

Cris S Constantinescu

Professor, Division of Clinical Neurology, University of Nottingham, Queen's Medical Centre

Dr Constantinescu’s interests include neuroimmunology, multiple sclerosis, experimental models of demyelinating disease, immunologic tolerance, cytokines and neuroimaging. He has authored over 100 peer reviewed articles and is an invited speaker at national and international institutions. He is former recipient of the Physician Scientist Award from the NIH, and Research Grants and Awards from the American Neurological Association. Society affiliations include: Association of British Neurologists, American Academy of Neurology, British Society of Immunology, American Academy of Neurology, European Neuro-Ophthalmology Society (EUNOS), American Association of Immunologists Society for Leukocyte Biology, British Medical Association, American Neurological Association, and International Society of Neuroimmunology.

View Press Release - Prof. Constantinescu becomes European Neurological Review Editor-in-Chief here.


Francois Bethoux, MD - Director, Rehabilitation Services, Mellen Center for Multiple Sclerosis, The Cleveland Clinic

Francois Bethoux, MD

Director, Rehabilitation Services, Mellen Center for Multiple Sclerosis, The Cleveland Clinic

Dr. Bethoux is a principal or co-investigator in a number of research studies in the area of multiple sclerosis rehabilitation, ambulation, and spasticity management. Dr. Bethoux has spoken both nationally and internationally on these topics. Dr. Bethoux's work has been published in many peer-reviewed medical journals. Dr Bethoux also authored several book chapters and co-edited a book on outcome measures for rehabilitation.

Dr. Bethoux has contributed to several expert panels. He currently chairs the Research Interest Group on symptom management of the Consortium of Multiple Sclerosis Centers. He is a member of the American Academy of Neurology and of the International Society for Quality of Life Research.

Latest Articles

Latest Videos

Video List based on Category on Node Page

Latest Videos

David Hafler (Yale School of Medicine, CT) considers recent developments in understanding of genetic risk, as well as the roles of regulatory T cells and B cells in multiple sclerosis (MS), and shares his view on what he considers to be the most important therapeutic targets in MS and remaining...
Cris Constantinescu (University of Nottingham, Queen's Medical Centre, UK), our Editor-in Chief of European Neurological Review, discusses the background and findings of his presentation comparing the immunomodulatory activity of mesenchymal stem cells from patients with secondary progressive...
Mark Freedman (Ottawa Hospital and Ottawa Hospital Research Institute), a recent welcome addition to our editorial board for US Neurology, considers treatment biomarkers in multiple sclerosis including discussion around his presentation on neurofilament light chain (NF-L) levels before and after...

Multiple Sclerosis INSIGHTS

The touchNEUROLOGY website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of neurology:

Insight
Highlights from the 70th Annual AAN Meeting 2018: focus on multiple sclerosis

Katrina Mountfort, Freelance Medical Writer for Touch Medical Media, UK
Tim Sheldrick, Group Director and Advisory Editor, Touch Medical Media, UK

Insight
Smart devices in the management of multiple sclerosis

Katrina Mountfort, Freelance Medical Writer for Touch Medical Media, UK

Interview
Interview with Sarah Sheikh, Senior Medical Director, Biogen, Cambridge, MA, US

Katrina Mountfort, Freelance Medical Writer for Touch Medical Media, UK

Insight
No evident disease activity (NEDA) may become the new standard for disease control in multiple sclerosis

Catherine Amey, Senior Medical Writer, Touch Medical Media, Goring-On-Thames, Reading, UK

Insight
B-cell proliferation following alemtuzumab treatment may create new autoimmunities in patients with multiple sclerosis

Catherine Amey, Senior Medical Writer, Touch Medical Media, Reading, UK